CENTOGENE AG (CENTOGENE) and Interactive Biosoftware (IBS) announce to start their collaboration on the integration of CENTOGENE’s unique genomic database CentoMD® and Alamut® Visual, the decision-support software from IBS. With joining forces for providing genetic variant interpretation data, both companies expand the support for the medical community to reach the most complete information at one spot.
CentoMD®, the world’s largest genomic database for rare disease, maintains with its recent release v3.1 approx. 3 million identified alleles, disease-associated polymorphisms, benign polymorphisms and other known variants of undetermined significance, thereof 57% of unpublished data. CentoMD® encompasses genetic information and clinical data from more than 100,000 people worldwide.